The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration
Author:
Affiliation:
1. Institute of Pathology; Catholic University of the Sacred Heart; Rome Italy
2. Institute of Urology; Catholic University of the Sacred Heart; Rome Italy
3. Institute of Oncology; Catholic University of the Sacred Heart; Rome Italy
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference22 articles.
1. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder;Babjuk;Eur Urol,2008
2. Guideline for the management of nonmuscle invasive bladder cancers (stages Ta, T1, and Tis): 2007 update;Hall;J Urol,2007
3. The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review;Lammers;Eur Urol,2011
4. New frontiers in intravesical therapies and drug delivery;Giannantoni;Eur Urol,2006
5. Alternating mitomycin C and BCG instillations versus BCG alone in treatment of carcinoma in situ of the urinary bladder: a Nordic study;Kaasinen;Eur Urol,2003
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples;International Journal of Molecular Sciences;2023-08-06
2. Conductive hyperthermic chemotherapy versus electromotive drug administration of mitomycin C as intravesical adjuvant treatment of patients with intermediate or high-risk non-muscle invasive bladder cancer;Urologic Oncology: Seminars and Original Investigations;2023-02
3. DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high‐risk group;Cancer Cytopathology;2022-10-19
4. Evaluation of bladder washings cytology in diagnosis of neoplasms of urinary bladder;IP Archives of Cytology and Histopathology Research;2022-03-15
5. Negative for High-Grade Urothelial Carcinoma (NHGUC);The Paris System for Reporting Urinary Cytology;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3